A solution containing 1mg/ml of the antibody in a buffer solution of PBS at pH 7.4 with 0.1% Sodium Azide.
Killer Cell Immunoglobulin-Like Receptors (KIRs) are a family of transmembrane glycoproteins expressed primarily on natural killer (NK) cells and subsets of T cells. These receptors play a crucial role in the regulation of the immune response by interacting with human leukocyte antigen (HLA) class I molecules. KIRs are highly polymorphic and are encoded by genes located in a cluster on chromosome 19q13.4 within the leukocyte receptor complex (LRC).
KIRs are classified based on the number of extracellular immunoglobulin (Ig) domains and the length of their cytoplasmic tails. KIR2DL3, specifically, is characterized by having two Ig domains and a long cytoplasmic tail. The long cytoplasmic tail contains immune tyrosine-based inhibitory motifs (ITIMs), which are responsible for transducing inhibitory signals upon ligand binding .
The primary function of KIR2DL3 is to inhibit the activity of NK cells. When KIR2DL3 binds to its ligands, which are specific HLA-C molecules, it transduces inhibitory signals through its ITIMs. This interaction prevents the NK cells from killing the target cells, thereby maintaining self-tolerance and preventing autoimmunity .
KIR2DL3 is expressed on the surface of NK cells and some T cell subsets. The expression of KIRs, including KIR2DL3, is stochastic and variegated, meaning that different NK cells express different combinations of KIRs. This diversity in KIR expression contributes to the versatility and adaptability of the immune response .
The KIR gene family is highly polymorphic, with multiple alleles and haplotypes present in the human population. This genetic diversity allows for a wide range of immune responses and is thought to be an evolutionary adaptation to diverse pathogenic challenges. The polymorphism of KIR genes, including KIR2DL3, also has implications for disease susceptibility and transplant compatibility .
KIR2DL3 and other KIRs have been implicated in various clinical conditions. For example, certain KIR-HLA combinations are associated with a higher risk of developing autoimmune diseases, such as rheumatoid arthritis and psoriasis. Additionally, KIR2DL3 has been studied in the context of hematopoietic stem cell transplantation, where the compatibility of KIR-HLA interactions can influence transplant outcomes .
Mouse anti-human KIR2DL3 antibodies are used in research to study the expression and function of KIR2DL3. These antibodies can be used in various applications, including flow cytometry, immunoprecipitation, and immunohistochemistry, to detect and analyze KIR2DL3 on human cells. The use of mouse anti-human antibodies allows for the specific targeting of human KIR2DL3, facilitating the study of its role in immune regulation .